Narrow Results

INDIA – Zinc Treatment for Infections in Children.

JAPAN – Japan Pharma Portfolio Finds Renewed Strength through Record Growth in 2012.

JAPAN – Joint Development of a Novel Lyophilized Dual Chamber Prefillable Syringe System.

JAPAN – A Genetic Alternative to Fertilizer.

SINGAPORE – Made-in-Singapore H5N1 Bird Flu Diagnostic Kit - Detects All Known Strains of H5N1 Virus with a Single Test.

THAILAND – KEEEN, Thai Bioremediation Product, Awarded Gold Medal for "Bioremediation Agent developed to Greenovation Product".

EUROPE – MorphoSys Antibody Reaches Major Milestone in Collaboration with Roche.

EUROPE – New Technique to Predict Heart Attacks.

USA – FEI Launches 'Living Lab' for Structural Biology Research at NIH.

USA – Synthetic Platelets Built to Treat Bleeding.

USA – Software Scans Tongue for Signs of Disease.

USA – US Legislation Will Ensure Tighter Checks on Foreign Drug Factories.

INDIA – A novel form of gene regulation in bacteria.

INDIA – Algal biofuels are no energy panacea.

JAPAN – Medical Data Vision enhances the quality of medical care with Actian Vectorwise.

SINGAPORE – Singapore heart surgeon to receive honour from The Royal College of Surgeons of Edinburgh.

SINGAPORE – ELGA^® to deliver innovative water purification at new Singapore General Hospital expansion.

AUSTRALIA – Specialised Therapeutics Australia: New drug to fight hospital superbug infection.

AUSTRALIA – Group of genes hold the clue in migraine cases.

AUSTRALIA – CT scans can triple risk of brain cancer, leukemia.

BRAZIL – Science can do more for sustainable development.

MIDDLE EAST – Particles and persecution: why we should care about Iranian physicists.

EUROPE – Medicyte coordinates EU-funded collaboration on Biomimetic Bioartificial Liver.

EUROPE – Selvita and Orion Pharma achieve a research milestone in Alzheimer's Disease Program.

EUROPE – Zinforo (ceftaroline fosamil) receives positive CHMP opinion in the European Union for the treatment of patients with serious skin infections or community acquired pneumonia.

USA – Vein grown from girl's own stem cells transplanted.

USA – Hidden vitamin in milk yields remarkable health benefits - Weill Cornell researchers show tiny vitamin in milk, in high doses, makes mice leaner, faster and stronger.

USA – New report finds biotechnology companies are participating in 39% of all projects in development for new medicines and technologies for neglected diseases.

USA – TriReme Medical receives FDA clearance for expanded matrix of sizes of Chocolate PTA balloon catheter.

USA – New data show investigational compound dapagliflozin demonstrated significant reductions in blood sugar levels when added to sitagliptin in adults with type 2 diabetes at 24 weeks, with results maintained over 48 weeks.

USA – Zalicus successfully completes Phase 1 single ascending dose study with Z944, a novel, oral T-Type Calcium Channel Blocker.

USA – Study provides clues to clinical trial cost savings.

Vaccines: Where are we headed?

Cancer Vaccines – History, Recent Breakthroughs and Commercial Perspectives.

Virus Sensitizer Technology: A New Boost for Cell-Based Vaccine Production.

A Novel Method for Making Pandemic Influenza Vaccines.

Fosun Pharmaceutical and Shanghai drugs open innovation model.

QIAGEN gains SFDA approval to market careHPV Test.

AstraZeneca's heart drug wins approval.

SIMM explores a novel cationic core-shell lipo-nanoparticles for ocular gene drug delivery.

TaiGen and TTY Biopharm jointly develop and commercialize a novel topoisomerase I inhibitor for cancer treatment.

iHuman Institute inauguration held.

Sihuan Pharmaceutical collaborates with NeuroVive to develop two innovative cardio-cerebral vascular products.

PerkinElmer acquires China-based infectious disease diagnostics company.

The Biotechnology Incubation Center of Academia Sinica: A Gateway to Innovative Taiwan.

Cancer Targeting Nanomedicine: An Opportunity for Drug Development in Asia with Emphasis on Taiwan.

Recombinant Lipoproteins for the Development of Novel Subunit Vaccines.

Discovery of Therapeutic Human Monoclonal Antibodies through B-cell Immortalization Technology.

Malaysian Bio-XCell Sdn Bhd seals a deal exceeding US$35 (~RM107m) with Agila Biotech Sdn Bhd during BioPharma Asia 2013.

Nagasaki University and Astellas launch collaborative research for screening new anti-dengue virus drugs for neglected tropical diseases.

Eurofins collaborates with AB SCIEX and Phenomenex to improve analysis of animal feed.

Biolife Science $5m ASX listing to progress stomach & breast cancer vaccine.

Naz Haji appointed Chief Information Officer, Quintiles Asia markets.

Roche and BioLamina start collaboration to develop novel cell culture systems.

BioScience Managers banks on growth of anti-infectives market.

Rodin Therapeutics applies insights of epigenetics to neurological disorders.

LBT Innovations finalizes joint venture to drive global production of world-class automated diagnostics technology.

Phylogica expands collaborations with Janssen for peptide-drug conjugates.

Immune Design and Medicago announce license agreement and collaboration to develop novel adjuvanted pandemic influenza vaccines.

Bayat Foundation inaugurates new pediatric critical care facility at Indira Gandhi Hospital in Kabul.

Vaccines Have No Bounds: The Future of Therapeutic Vaccines Against Cancer, Allergy, Heart Disease, Drug Addiction and Other Novel Indications.

Rational Design for the Next Generation of Vaccines.

Evaluating Asia Pacific for the Conduct of Vaccine Clinical Trials.

Stratify, Stratify, and Stratify: The Future of Life-Course Vaccination.

Process Intensification in the New Bio-Therapeutics Era.

Innovation in Academic Medicine.

Merck Serono awards Grant for Growth Innovation (GGI) for the first time.

National Cancer Institute awards KIYATEC nearly $2M to fund 3D breast cancer, 3D brain cancer micro-tumor development.

Frost & Sullivan honors 2014 Growth, Innovation & Leadership Award winners.

Abcam licenses novel Ceefourin inhibitors of multidrug resistance protein 4 from Australia's Children's Cancer Institute.

Daiichi Sankyo further expands TaNeDS collaborative drug discovery program in Europe.

Veolia Water Technologies South-East Asia to provide advanced water solutions for Tun Razak Exchange Project in Malaysia.

Biocept and Rosetta Genomics collaborate to evaluate microRNAs from circulating tumor cells.

Biocept expands collaboration with MD Anderson Cancer Center.

In this research, nanocrystalline titanium dioxide (TiO₂) particles were prepared by a modified alkoxide technique under basic and acidic conditions at room temperatures. A simple method for preparing different morphology of TiO₂ has been developed. The reaction condition was used to control the crystalline size, phase and morphology of the TiO₂ nanostructures. In this process by adjusting the R_w (water to precursor ratio) and pH value the hydrolysis and condensation reactions were controlled. This led to the development of a new process to produce TiO₂ nanorod (for the first time by sol–gel method) at high pH value (basic) while the water content was sufficient whereas at low pH value (acidic) nanosphere TiO₂ were obtained. The powders were characterized by DTA, XRD, FE-SEM and UV–vis techniques and their physical properties were compared.

Heart sound (HS) analysis or auscultation is a standout amongst the most simple, non-invasive and costless methods used to evaluate heart health and is one of the basic and foremost routine of a doctor while reviewing a patient. Detecting cardiac abnormality by auscultation demands a physician’s experience and even then there is a high scope of committing error. In this paper, a low cost electronic stethoscope is built to acquire HS in a novel manner by taking one from each ventricular and auricular area and superimposed, to get a resultant signal of both distinct lub-dub sound. Then, a light, fast and low computation speed beat track method followed by wavelet reconstruction is presented for correct detection of S1 and S2. It is done without ECG reference, and can be used satisfactorily on both normal and pathological HSs. Moreover, heartbeats can be identified in both de-noised and noised environment as it is independent of external disturbances. Significant features are extracted from the resultant HSs with detected S1 and S2 and feed-forward back propagation method. It is used to classify the HS nature into normal and pathological. This algorithm has been implemented on 24 pairs of HSs, extracted from 24 patients of 15 pathological and nine normal subjects and the classification yields a result of 91.7% accuracy with 81.8% sensitivity. The overall performance suggests a good performance to cost ratio. This system can be used as first diagnosis tool by the medical professionals.